1 / 10

Aarkstore - Grifols Therapeutics, Inc. - Pharmaceuticals

Grifols Therapeutics, Inc. (Grifols) formerly Talecris Biotherapeutics Inc, is a US-based publicly held pharmaceutical company. It engages in development, production, marketing and distribution of therapies for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases and severe trauma. Browse Full Report @ http://bit.ly/1tgUUMm

addyparker2350
Download Presentation

Aarkstore - Grifols Therapeutics, Inc. - Pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category : Pharmaceuticals & Healthcare Grifols Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Browse Complete Report - http://www.aarkstore.com/pharmaceuticals-healthcare/26310/grifols-therapeutics-inc-pharmaceuticals-healthcare-deals-and-alliances-profile

  2. Summary Grifols Therapeutics, Inc. (Grifols) formerly Talecris Biotherapeutics Inc, is a US-based publicly held pharmaceutical company. It engages in development, production, marketing and distribution of therapies for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases and severe trauma. The companys product portfolio comprises of gamunex, an immune globulin intravenous used to treat infectious or inflammatory diseases; hypermunes, a hyperimmune globulin therapy used to treat patients with weak immune systems; koate-DVI is an antihemophilic factor used for treatment of persons with hemophilia; plasbumin, a protein produced by the liver used for the treatment of shock and blood loss due to trauma, burns, and surgery; prolastin; and thrombate III for the treatments of lungs and spontaneous clotting, respectively. Its geographic operations are spread across the US, Canada and Europe. The company received orphan drug designation from the US FDA for its aerosolized Alpha1-Proteinase Inhibitor (Human, A1PI), for the treatment of congenital alpha1-antitrypsin (AAT) deficiency. Grifols is headquartered in Research Triangle Park, the US.

  3. Scope - Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

  4. Reasons to Buy Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.Understand the companys business segments expansion / divestiture strategy- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

  5. Table of Content Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7Grifols Therapeutics, Inc., Medical Devices Deals, 2008 to YTD 2014 8Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 10Asset Purchase 10Talecris BioTherapeutics Acquires Three Plasma Centers From International BioResources 10Partnerships 12Talecris Biotherapeutics Enters Into Co-Promotion Agreement With Novartis Vaccines And Diagnostics 12

  6. List of Tables Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts 1Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6Grifols Therapeutics, Inc., Deals By Therapy Area, 2008 to YTD 2014 7Grifols Therapeutics, Inc., Medical Devices Deals, 2008 to YTD 2014 8Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9

  7. List of Figures Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 5Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6Grifols Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7Grifols Therapeutics, Inc., Medical Devices Deals, 2008 to YTD 2014 8

  8. Related Reports Regis Healthcare Ltd : Company Profile and SWOT Analysis Taisho Pharmaceutical Holdings Co., Ltd. : Company Profile and SWOT Analysis Catalent, Inc. : Company Profile and SWOT Analysis Immune Pharmaceuticals, Inc. (IMNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile CEL-SCI Corporation (CVM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Grifols Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Global Regenerative Medicine Market 2015-2019 Japanese Encephalitis - Pipeline Review, H2 2014

  9. Grifols Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Published: Dec. 2014 | 25 Pages Grifols Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. Price

  10. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news

More Related